Home About Us Products Clinical Trials News Investors Contact Declarations The information on this website is being disclosed in accordance with AIM Rule 26. The ordinary shares in ReNeuron Group plc (the “Company”) have not been nor will they be, registered under the US Securities Act of 1933, as amended, or with any securities regulatory authority of any state or other jurisdiction of the United States or under the applicable securities laws of Australia, Canada, Japan or the Republic of South Africa. Subject to certain exceptions, the ordinary shares in the Company may not be offered or sold in the United States, Australia, Canada, Japan or the Republic of South Africa or to or for the account or benefit of any national, resident or citizen of Australia, Canada, Japan or the Republic of South Africa or any person located in the United States. Section: Investors The financial year in review to March 2021 The financial year in review to March 2020 The financial year in review to March 2019 Email alerts General Meetings Investor Centre Corporate Governance Share Price Information Analyst Research Advisors Webcasts and Presentations Financial Reports Financial Calendar Major Shareholdings RNS Notifications Documents and Circulars Declarations Subscribe here for our Press Releases: The information collected will be used to send you the information you have requested and to provide information that may be useful to you. ReNeuron may share non-personal aggregate statistics (group) data about ReNeuron’s website visitors with partners or other parties. However, ReNeuron will not sell or share any information about individual users. Please ensure you have read the full contents of our Privacy Notice before continuing. If you agree to your information being used in this way, please tick the box: I agree Click here © ReNeuron Group plc 2021 All rights reserved Website design by Carr Kamasa Design Privacy Notice Disclaimer